Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Suh

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Urologic Oncology|March 29, 2021
Comprehensive genomic profiling of metastatic collecting duct carcinoma, renal medullary carcinoma, and clear cell renal cell carcinomaGennady Bratslavsky, Stephanie Gleicher, Joseph M Jacob, et al.
European Urology Focus|July 21, 2018
Genomic Characterization of Testicular Germ Cell Tumors Relapsing After ChemotherapyAndrea Necchi, Gennady Bratslavsky, Robert J Corona, et al.
Cancer|October 20, 2015
Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapiesRami N Al-Rohil, Ashley J Tarasen, J Andrew Carlson, et al.
Plos One|November 28, 2018
Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLCMichael E Goldberg, Meagan Montesion, Lauren Young, et al.
The Oncologist|October 29, 2017
<i>ALK</i> Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted TherapyJeffrey S Ross, Siraj M Ali, Omotayo Fasan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2017
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic ProfilingAlexa B Schrock, Shuyu D Li, Garrett M Frampton, et al.
Cancer Research|January 11, 2017
Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor SpectraJuliann Chmielecki, Mark Bailey, Jie He, et al.
The Oncologist|September 16, 2017
Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation SignaturesAdrienne Johnson, Eric Severson, Laurie Gay, et al.
Cell|September 18, 2012
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencingMarcin Imielinski, Alice H Berger, Peter S Hammerman, et al.
Cell|August 6, 2021
A proteogenomic portrait of lung squamous cell carcinomaShankha Satpathy, Karsten Krug, Pierre M Jean Beltran, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Urologic Oncology|March 29, 2021
Comprehensive genomic profiling of metastatic collecting duct carcinoma, renal medullary carcinoma, and clear cell renal cell carcinomaGennady Bratslavsky, Stephanie Gleicher, Joseph M Jacob, et al.
European Urology Focus|July 21, 2018
Genomic Characterization of Testicular Germ Cell Tumors Relapsing After ChemotherapyAndrea Necchi, Gennady Bratslavsky, Robert J Corona, et al.
Cancer|October 20, 2015
Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapiesRami N Al-Rohil, Ashley J Tarasen, J Andrew Carlson, et al.
Plos One|November 28, 2018
Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLCMichael E Goldberg, Meagan Montesion, Lauren Young, et al.
The Oncologist|October 29, 2017
<i>ALK</i> Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted TherapyJeffrey S Ross, Siraj M Ali, Omotayo Fasan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2017
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic ProfilingAlexa B Schrock, Shuyu D Li, Garrett M Frampton, et al.
Cancer Research|January 11, 2017
Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor SpectraJuliann Chmielecki, Mark Bailey, Jie He, et al.
The Oncologist|September 16, 2017
Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation SignaturesAdrienne Johnson, Eric Severson, Laurie Gay, et al.
Cell|September 18, 2012
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencingMarcin Imielinski, Alice H Berger, Peter S Hammerman, et al.
Cell|August 6, 2021
A proteogenomic portrait of lung squamous cell carcinomaShankha Satpathy, Karsten Krug, Pierre M Jean Beltran, et al.
Pageof 3